Clinical implications of Schwann cell biology

Journal of the Peripheral Nervous System

Volumn 19, Issue 1, 2014, Pages 14-23

  Armati, Patricia J ^a   Mathey, Emily K ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

neuropathy; peripheral nervous system; perisynaptic Schwann cell; satellite cell; Schwann cell

Indexed keywords

VOLTAGE GATED POTASSIUM CHANNEL; VOLTAGE GATED SODIUM CHANNEL;

AUTOIMMUNITY; CHRONIC PAIN; CONFERENCE PAPER; CYTOLOGY; DEGENERATIVE DISEASE; GENE MUTATION; GLIA CELL; HUMAN; INHERITED NEUROPATHY; LIPID METABOLISM; MITOCHONDRION; NEURAL CREST CELL; NEUROLOGIC DISEASE; NEUROMUSCULAR SYNAPSE; NEUROPATHY; NONHUMAN; PERIPHERAL NERVE; PERIPHERAL NERVOUS SYSTEM FUNCTION; PERIPHERAL NEUROPATHY; PERISYNAPTIC SCHWANN CELL; PRIORITY JOURNAL; SATELLITE CELL; SCHWANN CELL; SENSORY NERVE CELL; SYNAPSE; TRIPARTITE SYNAPSE;

NEUROPATHY; PERIPHERAL NERVOUS SYSTEM; PERISYNAPTIC SCHWANN CELL; SATELLITE CELL; SCHWANN CELL;

HUMANS; MUTATION; NEURAL CREST; NEUROGLIA; NEURONS; PERIPHERAL NERVOUS SYSTEM; PERIPHERAL NERVOUS SYSTEM DISEASES; SCHWANN CELLS;

EID: 84895747496     PISSN: 10859489     EISSN: 15298027     Source Type: Journal    
DOI: 10.1111/jns5.12057     Document Type: Conference Paper

References (43)

1. Auld DS, Robitaille R, (2003). Perisynaptic Schwann cells at the neuromuscular junction: nerve- and activity-dependent contributions to synaptic efficacy, plasticity, and reinnervation. Neuroscientist 9: 144-157.
2. Chen Y, Li G, Huang LY, (2012). P2X7 receptors in satellite glial cells mediate high functional expression of P2X3 receptors in immature dorsal root ganglion neurons. Mol Pain 8: 9.
3. Chernousov MA, Yu WM, Chen ZL, Carey DJ, Strickland S, (2008). Regulation of Schwann cell function by the extracellular matrix. Glia 56: 1498-1507.
4. Chernousov MA, Stahl RC, Carey DJ, (2013). Tetraspanins are involved in Schwann cell-axon interaction. J Neurosci Res 91: 1419-1428.
5. Cifuentes-Diaz C, Dubourg O, Irinopoulou T, Vigny M, Lachkar S, Decker L, Charnay P, Denisenko N, Maisonobe T, Leger JM, Viala K, Hauw JJ, Girault JA, (2011). Nodes of Ranvier and paranodes in chronic acquired neuropathies. PLoS One 6: e14533.
6. Colomar A, Robitaille R, (2004). Glial modulation of synaptic transmission at the neuromuscular junction. Glia 47: 284-289.
7. Devaux JJ, Odaka M, Yuki N, (2012). Nodal proteins are target antigens in Guillain-Barré syndrome. J Peripher Nerv Syst 17: 62-71.
8. Dreesmann L, Mittnacht U, Lietz M, Schlosshauer B, (2009). Nerve fibroblast impact on Schwann cell behavior. Eur J Cell Biol 88: 285-300.
9. Feng Z, Ko CP, (2008a). Schwann cells promote synaptogenesis at the neuromuscular junction via transforming growth factor-beta1. J Neurosci 28: 9599-9609.
10. Feng Z, Ko CP, (2008b). The role of glial cells in the formation and maintenance of the neuromuscular junction. Ann N Y Acad Sci 1132: 19-28.
11. Furusho M, Dupree JL, Bryant M, Bansal R, (2009). Disruption of fibroblast growth factor receptor signaling in nonmyelinating Schwann cells causes sensory axonal neuropathy and impairment of thermal pain sensitivity. J Neurosci 29: 1608-1614.
12. Gosselin RD, Suter MR, Ji R-R, Decosterd I, (2010). Glial cells and chronic pain. Neuroscientist 16: 519-531.
13. Griffin JW, Sheikh K, (1999). Schwann cell-axon interactions in Charcot-Marie-Tooth disease. Ann N Y Acad Sci 883: 77-90.
14. Griffin JW, Thompson WJ, (2008). Biology and pathology of nonmyelinating Schwann cells. Glia 56: 1518-1531.
15. Halstead SK, Humphreys PD, Goodfellow JA, Wagner ER, Smith RA, Willison HJ, (2005a). Complement inhibition abrogates nerve terminal injury in Miller Fisher syndrome. Ann Neurol 58: 203-210.
16. Halstead SK, Morrison I, O'Hanlon GM, Humphreys PD, Goodfellow JA, Plomp JJ, Willison HJ, (2005b). Anti-disialosyl antibodies mediate selective neuronal or Schwann cell injury at mouse neuromuscular junctions. Glia 52: 177-189.
17. Hanani M, (2012). Intercellular communication in sensory ganglia by purinergic receptors and gap junctions: implications for chronic pain. Brain Res 1487: 183-191.
18. Hanani M, Huang TY, Cherkas PS, Ledda M, Pannese E, (2002). Glial cell plasticity in sensory ganglia induced by nerve damage. Neuroscience 114: 279-283.
19. Kawamura N, Yamasaki R, Yonekawa T, Matsushita T, Kusunoki S, Nagayama S, Fukuda Y, Ogata H, Matsuse D, Murai H, Kira JI, (2013). Anti-neurofascin antibody in patients with combined central and peripheral demyelination. Neurology 81: 714-722.
20. Kawasaki Y, Xu ZZ, Wang X, Park JY, Zhuang ZY, Tan PH, Gao YJ, Roy K, Corfas G, Lo EH, Ji RR, (2008). Distinct roles of matrix metalloproteases in the early- and late-phase development of neuropathic pain. Nat Med 14: 331-336.
21. Ko CP, Sugiura Y, Feng Z, (2007). The biology of perisynaptic (terminal) Schwann cells. In: The Biology of Schwann Cells., Armati PJ, (Ed). Cambridge University Press, Cambridge, pp 72-99.
22. Kubicek L, Kopacik R, Klusakova I, Dubovy P, (2010). Alterations in the vascular architecture of the dorsal root ganglia in a rat neuropathic pain model. Ann Anat 192: 101-106.
23. Li D, Wang L, Lee CW, Dawson TA, Paterson DJ, (2007). Noradrenergic cell specific gene transfer with neuronal nitric oxide synthase reduces cardiac sympathetic neurotransmission in hypertensive rats. Hypertension 50: 69-74.
24. Lindner M, Ng JK, Hochmeister S, Meinl E, Linington C, (2013). Neurofascin 186 specific autoantibodies induce axonal injury and exacerbate disease severity in experimental autoimmune encephalomyelitis. Exp Neurol 247C: 259-266.
25. Lonigro A, Devaux JJ, (2009). Disruption of neurofascin and gliomedin at nodes of Ranvier precedes demyelination in experimental allergic neuritis. Brain 132: 260-273.
26. Lupski JR, de Oca-Luna RM, Slaugenhaupt S, Pentao L, Guzzetta V, Trask BJ, Saucedo-Cardenas O, Barker DF, Killian JM, Garcia CA, Chakravarti A, Patel PI, (1991). DNA duplication associated with Charcot-Marie-Tooth disease type 1A. Cell 66: 219-232.
27. Martin LJ, (2012). Biology of mitochondria in neurodegenerative diseases. Prog Mol Biol Transl Sci 107: 355-415.
28. Mathey EK, Derfuss T, Storch MK, Williams KR, Hales K, Woolley DR, Al-Hayani A, Davies SN, Rasband MN, Olsson T, Moldenhauer A, Velhin S, Hohlfeld R, Meinl E, Linington C, (2007). Neurofascin as a novel target for autoantibody-mediated axonal injury. J Exp Med 204: 2363-2372.
29. McLachlan EM, Janig W, Devor M, Michaelis M, (1993). Peripheral nerve injury triggers noradrenergic sprouting within dorsal root ganglia. Nature 363: 543-546.
30. Ng JK, Malotka J, Kawakami N, Derfuss T, Khademi M, Olsson T, Linington C, Odaka M, Tackenberg B, Pruss H, Schwab JM, Harms L, Harms H, Sommer C, Rasband MN, Eshed-Eisenbach Y, Peles E, Hohlfeld R, Yuki N, Dornmair K, Meinl E, (2012). Neurofascin as a target for autoantibodies in peripheral neuropathies. Neurology 79: 2241-2248.
31. Raeymaekers P, Timmerman V, Nelis E, De Jonghe P, Hoogendijk JE, Baas F, Barker DF, Martin JJ, De Visser M, Bolhuis PA, Van Broeckhoven C, HMSN Collaborative Research Group (1991). Duplication in chromosome 17p11.2 in Charcot-Marie-Tooth neuropathy type 1a (CMT 1a). The HMSN Collaborative Research Group. Neuromuscul Disord 1: 93-97.
32. Rossor AM, Polke JM, Houlden H, Reilly MM, (2013). Clinical implications of genetic advances in Charcot-Marie-Tooth disease. Nat Rev Neurol 9: 562-571.
33. Scherer SS, Arroyo EJ, (2002). Recent progress on the molecular organization of myelinated axons. J Peripher Nerv Syst 7: 1-12.
34. Scherer SS, Arroyo EJ, (2009). Myelin: molecular architecture of CNS and PNS myelin sheath. In: Encyclopedia of Neuroscience., Squire LR, (Ed). Academic Press, Oxford, pp 1169-1180.
35. Shinder V, Govrin-Lippmann R, Cohen S, Belenky M, Ilin P, Fried K, Wilkinson HA, Devor M, (1999). Structural basis of sympathetic-sensory coupling in rat and human dorsal root ganglia following peripheral nerve injury. J Neurocytol 28: 743-761.
36. Takahashi Y, Sipp D, Enomoto H, (2013). Tissue interactions in neural crest cell development and disease. Science 341: 860-863.
37. Uncini A, Susuki K, Yuki N, (2013). Nodo-paranodopathy: beyond the demyelinating and axonal classification in anti-ganglioside antibody-mediated neuropathies. Clin Neurophysiol 124: 1928-1934.
38. Verderio C, Matteoli M, (2011). ATP in neuron-glia bidirectional signalling. Brain Res Rev 66: 106-114.
39. Viader A, Golden JP, Baloh RH, Schmidt RE, Hunter DA, Milbrandt J, (2011). Schwann cell mitochondrial metabolism supports long-term axonal survival and peripheral nerve function. J Neurosci 31: 10128-10140.
40. Viader A, Sasaki Y, Kim S, Strickland A, Workman CS, Yang K, Gross RW, Milbrandt J, (2013). Aberrant Schwann cell lipid metabolism linked to mitochondrial deficits leads to axon degeneration and neuropathy. Neuron 77: 886-898.
41. Young P, Nie J, Wang X, McGlade CJ, Rich MM, Feng G, (2005). LNX1 is a perisynaptic Schwann cell specific E3 ubiquitin ligase that interacts with ErbB2. Mol Cell Neurosci 30: 238-248.
42. Zhang Y, Bekku Y, Dzhashiashvili Y, Armenti S, Meng X, Sasaki Y, Milbrandt J, Salzer JL, (2012). Assembly and maintenance of nodes of Ranvier rely on distinct sources of proteins and targeting mechanisms. Neuron 73: 92-107.
43. Zhou XF, Deng YS, Chie E, Xue Q, Zhong JH, McLachlan EM, Rush RA, Xian CJ, (1999). Satellite-cell-derived nerve growth factor and neurotrophin-3 are involved in noradrenergic sprouting in the dorsal root ganglia following peripheral nerve injury in the rat. Eur J Neurosci 11: 1711-1722.